Neurology

You are here

Learn More on Neuromodulation for the Management of Medication-Resistant Epilepsy

This activity is intended for neurologists, pediatricians, and primary care physicians.
September 20, 2018

Event Date:

March 28, 2018 - 12:00am

The goal of this activity is to provide an evidence-based rationale supporting the use of neuromodulation early in the course of the treatment of drug-resistant epilepsy (DRE) and offer guidance on patient selection for this therapy.

Upon completion of this activity, participants will have increased knowledge regarding the:

  • Identification of patients with drug-resistant epilepsy (DRE) who are candidates for neuromodulation
  • Available efficacy and safety data on the use of neuromodulation in patients with epilepsy

CME Released: 3/28/2018

Valid for credit through 3/28/2019

For more information and to register: click here

Weill Cornell Medicine Neurology 520 East 70th Street (at York Avenue) Starr Pavilion 607 New York, NY 10021 Phone: (212) 746-2596